Kangmei Pharmaceutical: Subsidiary Shanghai Kangmei acquires equity of two companies | Layout of medical devices

On September 29th, Kangmei Pharmaceutical announced that Kangmei Pharmaceutical announced on the evening of September 28 that Shanghai Kangmei Pharmaceutical Co., Ltd., a wholly-owned subsidiary, recently acquired 100% equity of Zhijian Medical with a total price of RMB 970,700 and a total price of RMB 9.39 million. Acquired 80% of the shares of Reiter Medical.

The announcement shows that the products that Qijian Medical intends to sell mainly include joints, trauma and spine. medical instruments The main business of Reiter Medical is the second category, the third category of orthopedic medical equipment sales, the main products are high-value consumables such as spine, joints and trauma equipment. After the completion of the acquisition, Kangmei Pharmaceutical will receive the above two Family enterprise Related terminal hospital Resources and medical device management qualifications will help the company expand its local business and increase market share.

Kangmei Pharmaceutical announced on the same day that Shanghai Kangmei signed an agreement with Shantou Huansheng Biotechnology Co., Ltd. on the same day. The two parties jointly established Kangmei Ruizhi Medical. Among them, Shanghai Kangmei invested 24 million yuan, holding 80% of shares, and Huansheng Biotech invested 6 million yuan. , holding 20%.

According to reports, Huansheng Biological has a wealth of medical device sales channels in the Chaoshan area. The new joint venture company will engage in the sales of orthopedics and other medical device products in the Chaoshan area, which will help increase the listed companies' orthopedics and other medical device products in the Chaoshan area. Sales channels, and expand the business of ophthalmology, consumables, microscopic consumables, etc., to enhance the company's competitiveness in the medical device sector.